Get started
AAA

ALZECURE PHARMA AB

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Seasonals

ALZCUR chart


Full chart

ALZCUR upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪111.69 M‬ SEK
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.505 SEK
Net income (FY)
‪−37.17 M‬ SEK
Revenue (FY)
0.00 SEK
Shares float
‪63.35 M‬
Beta (1Y)
0.11

Employees


Employees (FY)
11
Change (1Y)
−2 −15.38%
Revenue / Employee (1Y)
0.00 SEK
Net income / Employee (1Y)
‪−333.49 K‬ SEK

About ALZECURE PHARMA AB


Sector
Health Technology
Industry
Biotechnology
CEO
Martin Jönsson
Website
alzecurepharma.com
Headquarters
Huddinge
Founded
2016
ISIN
SE0010133785
FIGI
BBG00M6GTHQ2
AlzeCure Pharma AB is a pharmaceutical research company. It engages in the development of drug therapies for the treatment of severe diseases and conditions that affect the central nervous system. The firm is developing parallel drug candidates based on the research platforms, such as NeuroRestore, Alzstatin, and Painless. The company was founded by Johan Sandin, Gunnar Nordvall, Pontus Forsell, Johan Lundkvist, and Magnus Halldin on November 22, 2016 and is headquartered in Huddinge, Sweden.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

ALZCUR news



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of ALZCUR is 1.265 SEK — it has decreased by −8.33% in the past 24 hours. Watch ALZECURE PHARMA AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange ALZECURE PHARMA AB stocks are traded under the ticker ALZCUR.
ALZCUR stock has fallen by −19.17% compared to the previous week, the month change is a −29.72% fall, over the last year ALZECURE PHARMA AB has showed a −66.96% decrease.
We've gathered analysts' opinions on ALZECURE PHARMA AB future price: according to them, ALZCUR price has a max estimate of 6.00 SEK and a min estimate of 6.00 SEK. Watch ALZCUR chart and read a more detailed ALZECURE PHARMA AB stock forecast: see what analysts think of ALZECURE PHARMA AB and suggest that you do with its stocks.
ALZCUR reached its all-time high on Nov 4, 2020 with the price of 10.960 SEK, and its all-time low was 1.170 SEK and was reached on Nov 15, 2024. View more price dynamics on ALZCUR chart.
See other stocks reaching their highest and lowest prices.
ALZCUR stock is 19.66% volatile and has beta coefficient of 0.11. Track ALZECURE PHARMA AB stock price on the chart and check out the list of the most volatile stocks — is ALZECURE PHARMA AB there?
Today ALZECURE PHARMA AB has the market capitalization of ‪111.69 M‬, it has increased by 5.48% over the last week.
Yes, you can track ALZECURE PHARMA AB financials in yearly and quarterly reports right on TradingView.
ALZECURE PHARMA AB is going to release the next earnings report on Feb 27, 2025. Keep track of upcoming events with our Earnings Calendar.
ALZCUR net income for the last quarter is ‪−7.45 M‬ SEK, while the quarter before that showed ‪−8.65 M‬ SEK of net income which accounts for 13.94% change. Track more ALZECURE PHARMA AB financial stats to get the full picture.
No, ALZCUR doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 18, 2024, the company has 11.00 employees. See our rating of the largest employees — is ALZECURE PHARMA AB on this list?
Like other stocks, ALZCUR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ALZECURE PHARMA AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ALZECURE PHARMA AB technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ALZECURE PHARMA AB stock shows the strong sell signal. See more of ALZECURE PHARMA AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.